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Abstract
Antimicrobial susceptibility testing for Helicobacter pylori is increasingly important due to resis-
tance to the most used antimicrobials agents. Only agar dilution method is approved by CLSI, but it is
difficult to perform routinely. We evaluated the reliability of E-test and disk diffusion comparing to
agar dilution method on Helicobacter pylori antimicrobial susceptibility testing. Susceptibility test-
ing was performed for amoxicillin, clarithromycin, furazolidone, metronidazole and tetracycline us-
ing E-test, disk-diffusion and agar dilution method in 77 consecutive Helicobacter pylori strains
from dyspeptic children and adolescents. Resistance rates were: amoxicillin - 10.4%, 9% and 68.8%;
clarithromycin - 19.5%, 20.8%, 36.3%; metronidazole - 40.2%33.7%, 38.9%, respectively by agar
dilution, E-test and disk diffusion method. Furazolidone and tetracycline showed no resistance rates.
Metronidazole presented strong correlation to E-test (r = 0.7992, p < 0.0001) and disk diffusion
method (r=-0.6962, p < 0.0001). Clarithromycin presented moderate correlation to E-test (r = 0.6369,
p < 0.0001) and disk diffusion method (r=-0.5656, p < 0.0001). Amoxicillin presented weak correla-
tion to E-test (r = 0.3565, p = 0.0015) and disk diffusion (r=-0.3565, p = 0.0015). Tetracycline pre-
sented weak correlation with E-test (r = 0.2346, p = 0.04) and furazolidone to disk diffusion
(r=-0.0288, p = 0.8038). E-test presented better agreement with gold standard. It is an easy and reli-
able method for Helicobacter pylori susceptibility testing. Disk diffusion method presented high dis-
agreement and high rates of major errors.
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Introduction
Consensus recommends triple therapy to eradicate
Helicobacter pylori in infected children (Chey & Wong,
2007; Fock et al., 2009; Jones et al., 2005; Malfertheiner et
al., 2012). However in developing countries increasingly
antimicrobial resistance, mainly to metronidazole and
clarithromycin, is observed (Alvarez et al., 2009; Mendon-
ça et al., 2000; Ogata et al., 2013; Sherif et al., 2004; Wong
et al., 2003) and empirical treatment presents the risk of
eradication failure and/or development of secondary resis-
tance (Kalach et al., 2002; Molina-Infante & Gisbert, 2013;
Nguyen et al., 2012; Wong et al., 2003). Thus, antimi-
crobial susceptibility testing for Helicobacter pylori is
growing in importance (Chey & Wong, 2007; Graham &
Fischbach, 2010; Kalach et al., 2002; Malfertheiner et al.,
2012; Mégraud, 2004; Sykora & Rowland, 2011).
Therefore, it is necessary to validate a reproducible in
vitro susceptibility test to support the choice of antimicro-
bials drugs to eradicate H. pylori. The Clinical and Labora-
tory Standards Institute (CLSI) (National Committee for
Clinical Laboratory Standards, Approved standard M7-A5,
Informational supplement M100-S10, 2000) has approved
only agar dilution method, but it is time-consuming, la-
bor-intensive, and useful to simultaneously test a large num-
ber of strains. It is not adaptable to small numbers of strains,
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becoming impractical to perform routinely (Mégraud &
Lehours, 2007). Two alternative methods have been re-
ported, the Epsilometer test (E-test) and the disk diffusion
method. The E-test is a plastic strip containing increasing
gradients of antimicrobial concentration (AB Biodisk, Sol-
na, Sweden), and the MIC is read directly from the intersec-
tion of the elliptical zone of growth inhibition. This is the
current recommended phenotypic method, due to a stable
pattern of antibiotic release and a tolerance to prolonged in-
cubation, being an accurate method to test a fastidious organ-
ism like H. pylori. This is the main reason for why E-test, and
not disk diffusion method, has been recommended for
Helicobacter pylori susceptibilty testing. But it is more ex-
pensive (US$ 2.60 vs. US$ 0.026) (Mishra et al., 2006).
The disk diffusion uses a disk with a known concentra-
tion of antimicrobial, it is simple and easy to perform, eco-
nomical, and adaptable to clinical practice. But its a
qualitative method, results can be only susceptible or resis-
tant. And it is not standardized.
The difficulty to recommend one of these tests are the
discrepancies between the methods and a lack of standard-
ization to laboratory tests (Alarcon et al., 1998; Best et al.,
2003; Glupczynski et al., 2002; Grignon et al., 2002;
Hachem et al., 1996; Lang & Garcia, 2004; Midolo et al.,
1997; Mishra et al., 2006). The purpose of this study was to
assess the reliability of E-test and disk diffusion comparing
to the agar dilution method to evaluate Helicobacter pylori
antimicrobial susceptibility.
Patients and Methods
From February 2008 to August 2009, 77 consecutive
Helicobacter pylori isolates were obtained from children and
adolescents (range: 3 - 20 years, mean age = 11.1  3.9 y,
Median = 10.8 years; M/F: 1:1.08) who underwent endo-
scopic examination to evaluate dyspeptic symptoms at Hos-
pital São Paulo - Universidade Federal de São Paulo and
Cândido Fontoura Children´s Hospital, located respectively
at the south and east side of São Paulo City, Brazil.
The study was approved by the Institutional Review
Board of Universidade Federal de São Paulo and the legal re-
sponsible signed an informed consent form.
Biopsy sampling and bacterial strains: Two antral bi-
opsy specimens were collected and transported in Brain-
Heart Infusion (BHI) broth + glycerol (10%) at 4 °C. Gastric
biopsy specimens were homogenized and 5 L of the solu-
tion was inoculated into selective BHI agar base (DIFCO -
Lawrence, Kansas - USA) containing 7-10% defibrinated
sheep blood, vancomycin (10 mg/L), trimethoprim (5 mg/L),
cefsulodin (5 mg/L) and amphotericin B (5 mg/L)
(Helicobacter pylori selective Medium - Dent Supplement
Oxoid - Basingstoke, Hampshire - UK). All plates were in-
cubated for 10 days at 37 °C in a microaerobic atmosphere
(10% CO2, 85% N2, 5% O2) at 95% humidity - Microaerobac
- Probac do Brasil - São Paulo, Brazil). Helicobacter pylori
INCQS 00380 - ATCC 43504 strain was used as control. H.
pylori isolates were confirmed based on colony morphology,
positive urease, oxidase, and catalase reaction, and Gram
staining. Isolates were stored at -70 °C in BHI broth contain-
ing glycerol 30% until performing susceptibility test.
Susceptibility tests were performed using five mL of
frozen isolates that were subcultured on to BHI agar contain-
ing 10% defibrinated sheep blood and incubated for 3 days at
37 °C under microaerophilic conditions. The colonies were
suspended in BHI broth, adjusted to McFarland 4 turbidity
standard (approximately 1 x 108 cfu/mL), and then inocu-
lated into Mueller-Hinton agar, according each method. The
plates were incubated at 37 °C under microaerophilic condi-
tions (5% O2, 10% CO2 and 85% N2 at 95% humidity) for
72 h.
Agar dilution method was performed according to the
Clinical Laboratory Standards Institute (CLSI) protocols
(CLSI (2006) M7-A5). A multipoint replicating device was
used to deliver 2 L of inoculums in each plate. Breakpoint
to antimicrobials drugs recommendation was selected based
on CLSI or literature citations. The final concentrations of
clarithromycin (Abbott Laboratories - Chicago, Illinois -
USA), tetracycline, furazolidone and amoxicillin (Sigma
Aldritch Chemie - Steinheim, Germany) ranged from 0.015
to 64 g/mL, while metronidazole (Sigma Aldritch Chemie -
Steinheim, Germany) concentration ranged from 0.015 to
256 g/mL. The MICs values were the lowest antibiotic con-
centration that completely inhibited visible growth of the
bacteria.
E-test was performed to clarithromycin, tetracycline,
metronidazole and amoxicillin. Antimicrobial concentration
ranges from 0.016 to 256 g/mL. After inoculation the plates
were dried at 37 °C, then plastic strips (E-test) containing in-
creasing gradient of antimicrobial concentration (AB
Biodisk, Solna, Sweden) were applied onto surface of agar
plate. The MICs values were read as the interception of the
elliptical zone of inhibition with the graded strip for the E test
after 72 h.
MIC interpretative criteria: There is no standardized
MIC breakpoint for H. pylori, except to clarithromycin
(MIC  1 g/mL, and intermediary if MIC = 0.5 g/mL).
The MIC breakpoint for other antimicrobials was based on
the literature (MIC  2 g/mL to amoxicillin and furazo-
lidone;  4 g/mL to tetracycline, and,  8 g/mL to metro-
nidazole).
Disk diffusion uses disks containing 2 g of clarithro-
mycin, furazolidone, metronidazole and amoxicillin that
were placed on the dried and inoculated Mueller-Hinton
agar plates, results were read based on the diameters of the
zone growth inhibition. Metronidazole standard by CLSI to
disk diffusion: susceptible  21 mm, intermediary
16-21 mm, and resistant < 16 mm (Chaves et al., 1999). The
breakpoint to other antimicrobials was based on previous
studies with similar methodology: amoxicillin susceptible
1440 Ogata et al.
 25 mm and amoxicillin resistant < 25 mm, clarithromycin
susceptible  21 mm and clarithromycin resistant < 21 mm,
and furazolidone susceptible  13 mm and furazolidone re-
sistant < 21 mm.
Statistical analysis
The disagreement among the 3 tests was analysed by
McNemars test. MIC values analysis between E-test and
agar dilution, and MIC values analysis of agar dilution and
the disk diffusion inhibition zone diameter was performed
by Spearmans correlation test. Susceptibility tests were ex-
amined by error categorization.
Results
Figures 1-4 show the scattergrams comparing agar di-
lution and E-test MICs to metronidazole, amoxicillin, tetra-
cycline and clarithromycin, scattergram comparing the
diameter of inhibition zone of disk diffusion and agar dilu-
tion MIC to metronidazole, clarithromycin, amoxicillin and
furazolidone is showed in figure 5-8. The overall rate of
clarithromycin, furazolidone, metronidazole, tetracycline,
and amoxicillin resistance is shown in Table 1. Metronidazol
showed the highest resistance level: 40.2%, 33.7% and
39.9% by agar dilution method, E-test and disk diffusion, re-
spectively. The MIC90 value for agar dilution and E-test was
similar (64 g/mL, 3 log2 over recommended breakpoint).
There was a strong correlation (r = 0.7992, p < 0.0001) with
agar dilution and E-test, 5 (6.5%) isolates were discordant.
When compared to disk diffusion, disagreement occurred in
10%. The intermediary susceptibility to metronidazole by
disk difusion was observed in 27/77 (35%); these results
were exluded because difficult in comparison to agar dilu-
tion method. Nevertheless, strong correlation (r = -0.6962,
p < 0.0001) was observed with disk diffusion and agar dilu-
tion (Table 2).
Clarithromycin presented resistance rate of 19.5% by
agar dilution method and by E-test (20.8%); MIC90 was ob-
served near the breakpoint ( 1 g/mL). Disk diffusion
showed resistance in 38.9% (Table 1). Evaluating disagree-
ment to E-test, clarithromycin presented one intermediary
result by agar dilution that was resistant by E-test (1.3%) but
correlation was moderate (r = 0.6369, p < 0.0001) and dis-
agreement with disk diffusion occurred in 11.7%, 9 strains
were susceptible by agar dilution and resistant by disk diffu-
sion, but correlation was moderate (r= -0.5656, p < 0.0001)
(Table 2).
Amoxicillin showed 10.4% of resistance rate by agar
dilution and 9% by E-test, but presented the highest resis-
tance rate by disk diffusion (68.8%) (Table 1). Disagreement
between E-test and agar dilution occurred in one strain, that
was susceptible by agar dilution and resistant by E-test
(1.3%), but E-test showed a weak correlation (r = 0.3565,
p = 0.0015). Agar dilution presented the highest disagree-
ment (58.4%) and a weak correlation too (r = -0.3565,
p = 0.0015) (Table 2).
Tetracycline presented no resistant strains (0%) by
agar dilution method and by E-test, but correlation was
weak (r = 0.2346, p = 0.04). Furazolidone showed no re-
sistant strains (0%) by agar dilution and by disk diffusion,
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Figure 1 - Scattergram demostrating the correlation between agar dilution reference metronidazole MIC (resistant  8 g/mL - dotted line) and E-test
metronidazole MIC (resistant  8 g/mL - dashed line) determined on Muller-Hinton agar.
and presented weak correlation too (r = -0.0288,
p = 0.8038).
Interpretative error rate analysis (amoxicillin,
clarithromycin and metronidazole)
Very major error (VME)
That occurred when the bacteria was resistant (agar
dilution) and disk-diffusion method or E-test results were
susceptible. In this situation the patients are treated with the
antimicrobial, but eradication failure can occur;
Major error (ME)
When the bacteria was susceptible (agar dilution) and
diffusion test disk or E-test showed resistance. In this situa-
tion the patient doesn’t use the antimicrobial, but the treat-
ment could work;
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Figure 2 - Scattergram demostrating the correlation between agar dilution reference clarithromycin MIC (resistant  1 g/mL, and intermediary = 0.5
g/mL - dotted line) and E-test clarithromycin MIC (resistant  1 g/mL, and intermediary = 0.5 g/mL - dashed line) determined on Muller-Hinton agar.
Figure 3 - Scattergram demostrating the correlation between agar dilution reference tetracycline MIC (resistant  4 g/mL) and E-test tetracycline MIC
(resistant  4 g/mL) determined on Muller-Hinton agar.
Minor error (E)
The results where in the intermediary range of resis-
tance.
Disk diffusion method presented 94/231 (40.7%) er-
rors (59 ME and 35 E). E-test presented 13/107 (5.6%) er-
rors. Amoxicillin shows 1 VME with E-test (1.3%) and 45
ME by disk diffusion method (58.4%). Clarithromycin
showed 7 (9.1%) errors by E-test, 1 ME (1.3%) and 6
E (7.8%), by disk diffusion 17 (22.1%) errors occurred,
9 ME (11.7%) and 8 E (10.4%). Metronidazole presented
the highest rate of VME by E-test - 5 (6.5%), and by disk
diffusion - 5 ME (6.5%) and 27 E (41.5%).
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Figure 4 - Scattergram demostrating the correlation between agar dilution reference amoxicillin MIC (resistant  2 g/mL - dotted line) and E-test
amoxicillin MIC (resistant  2 g/mL - dashed line) determined on Muller-Hinton agar.
Figure 5 - Scattergram demostrating the correlation between agar dilution reference metronidazole MIC (resistant  8 g/mL - dotted line) and disk diffu-
sion metronidazole inhibition zone (susceptible  21 mm, intermediary 16-21 mm, and resistant < 16 mm - dashed line) determined on Muller-Hinton agar.
Technical and economical aspects
The main differences were the price of each test (U$ /
sample) and the time consumed to prepare each one.
Agar dilution needs a sequencial dilution of anti-
microbials and uses, in our study, 11 plates to be performed.
It cost U$ 37.26 and was the most laborious and time-
consuming test to prepare. However, we can evaluate 20
samples in each plate then the values can decrease to
U$ 1.86 / sample, but we need to collect all samples to per-
form the test.
E-test costs about U$ 45.60, but was the easiest and
simplest test to prepare. And each sample costs U$ 23.49 to
be evaluated by disk diffusion method. It is as simple to
prepare as E-test.
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Figure 6 - Scattergram demostrating the correlation between agar dilution reference clarithromycin MIC (resistant  1 g/mL, and intermediary = 0.5
g/mL - dotted line) and disk diffusion clarithromycin diameter of inhibition zone (resistant < 21 mm - dashed line) determined on Muller-Hinton agar.
Figure 7 - Scattergram demostrating the correlation between agar dilution reference furazolidone MIC (resistant  4 mg/mL) and disk diffusion
furazolidone diameter of inhibition zone (susceptible  13 mm and resistant < 21 mm - dashed line) determined on Muller-Hinton agar.
Discussion
Our results suggest that E-test is the best option to rou-
tinely performing susceptibility test for Helicobacter pylori.
The results are similar to other studies that consider E-test a
good method to clarithromycin and amoxicillin (Best et al.,
2003; Glupczynski et al., 1991; Hachem et al., 1996), with
good intra and interlaboratorial correlation (Glupczynski et
al., 2002). Despite the price.
Agreement and disagreement analysis of E-test and
agar dilution method showed the best agreement to tetracy-
cline (100%), followed by amoxicillin, clarithromycin and,
metronidazole, all of them presented agreement rate over
than 90%. Evaluation of MIC values presented low correla-
tion to amoxicillin, moderate to clarithromycin, and high to
metronidazole. These results show that despite good agree-
ment to discriminate susceptible and resistant isolates, MIC
can present a large range between both methods. Even a vari-
ation of 2 log2 in the MIC was not significant, not interfering
in the interpretation of susceptible and resistant strains.
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Figure 8 - Scattergram demostrating the correlation between agar dilution reference amoxicillin MIC (resistant  2 g/mL - dotted line) and disk diffu-
sion amoxicillin inhibition zone (resistant < 25 mm - dashed line) determined on Muller-Hinton agar.
Table 1 - Comparison of antimicrobials susceptibility test results by Agar dilution, E-test and Disk-diffusion method.
Antimicrobial Agent
Method Amoxicillin Clarithromycin Furazolidone Metronidazole Tetracycline
Agar Dilution MIC (g/mL) Range 0.015 - 2 0.015 - 4 0.015 - 0.06 0.015 - 256 0.015 - 2
MIC50 0.03 0.25 0.015 2.00 0.015
MIC90 1.00 1.00 0.03 64 1.00
N (%) of isolates Sensitive 69 (89.6) 62 (80.5) 77 (100) 46 (59.8) 77 (100)
Resistant 8 (10.4) 15 (19.5) 0 (0) 31 (40.2) 0 (0)
E-test MIC (g/mL) Range 0.016 - 16 0.016 - 2 0.016 - 256 0.016 - 2
MIC50 0.032 0.125 2 0.032
MIC90 1.00 1.00 64 0.5
N (%) of isolates Sensitive 70 (91) 61 (79.2) 51 (66.2) 77 (100)
Resistant 7 (9) 16 (20.8) 26 (33.8) 0 (0)
Disk-Diffusion mm Range 10 - 35 15 - 37 18 - 35 0 - 24
N (%) of isolates Sensitive 24 (31.2) 45a (63.7) 77 (100) 15b (18.2)
Resistant 53 (68.8) 24a (36.3) 0 (0) 35b (38.9)
a Eight strains excluded because of intermediate results by agar dilution.
b Twenty-seven strains excluded because of intermediate results by disk-difusion.
Metronidazole presented good correlation between
agar dilution and E-test method. However, literature shows
conflicting results. As our study, some authors observed
high correlation with the agar dilution method (Best et al.,
2003; Chaves et al., 1999; Osato, 2000; Tankovic et al.,
2001). Chaves et al. (Chaves et al., 1999) did not observed
significant differences between MIC of metronidazole by
agar dilution and E-test. But there was discrepancy in other
studies (Alarcon et al., 1998; Mégraud & Lehours, 2007).
The results of one study (Glupczynski et al., 2002) showed
a good correlation to the antimicrobials, except to metro-
nidazole that presented large range of inter and intralabora-
torial values of MIC. This difference was large (> 2log2)
and authors recommend to test the isolates in parallel to im-
prove the accuracy of E-test. The results need to be in ac-
ceptable level of MIC.
In opposition, disk diffusion method showed conflict-
ing and inconsistent results to amoxicillin (break-
point = 25 mm - 41.6%). The lack of standardization of the
breakpoint is a difficulty, in addition to variations in the
antimicrobial concentration in each disk. This study used
disks containing 2 g and breakpoint based on previous
studies with similar methodology. However, agreement
with gold-standard was lower than other studies (Lang &
Garcia, 2004; Midolo et al., 1997; Sung et al., 2009).
Clarithromycin (breakpoint = 21 mm - 83.1%), is the
unique antimicrobial standardized to disk diffusion (Grig-
non et al., 2002; Hachem et al., 1996; Midolo et al., 1997;
Warburton-Timms & McNulty, 2001). Comparing MIC by
agar dilution and E-test we observed mild correlation, re-
sults that were comparable to other studies. When disk dif-
fusion method used disks with 2 g of clarithromycin
concentration (MIC > 2 mg/L), discrepancies rarely oc-
curred. The breakpoint = 22 mm to clarithromycin has the
same discriminatory power than the MIC > 0.5 g/L
(Mégraud & Lehours , 2007).
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Table 2 - Analysis of disagreement and correlation of agar diffusion methods (E-test and Disk-diffusion) compared to Agar dilution method.
Antimicrobial agent Method
E-test Disk-diffusion
Disagreement - % (p) Correlation (p) Disagreement - % (p) Correlation (p)
Amoxicillin 1.3 (1) 0.3565 (0.0015) 58.4 (0.0001) -0.3565 (0.0015)
Clarithromycin 1.3 (1) 0.6369 (< 0.0001) 11.7 (0.0077) -0.5656 (< 0.0001)
Furazolidone -0.0288 (0.8038)
Metronidazole 6.5 (0.07) 0.7992 (< 0.0001) 10 (0.07) -0.6962 (< 0.0001)
Tetracycline 0.2346 (0.04)
Disagreement analysis - McNemar’s test
Correlation analysis - Spearmans correlation test
Table 3 - Interpretative error rate analysis to E-test and disk-diffusion.
Antimicrobial (N) Error E-test N (%) Disk-Diffusion N (%) Total N (%)
Amoxicillin (77) Very major 1 (1.3) 0 1 (2.2)
Major 0 45 (58.4) 45 (97.8)
Minor 0 0 46 (100)
1 (1.3) 45 (58.4)
Clarithromycin (77) Very major 0 0 0
Major 1 (1.3) 9 (11.7) 10 (41.7)
Minor 6 (7.8) 8 (10.4) 14 (58.3)
7 (9.1) 17(22.1) 24 (100)
Metronidazole (77) Very major 5 (5.6) 0 5 (13.5)
Major 0 5 (5.6) 5 (13.5)
Minor 0 27 (35.9) 27 (73)
5 (6.5) 32 (41.5) 37 (100)
Total Very major 6 (2.6) 0 6 (5.6)
Major 1 (0.4) 59 (25.5) 60 (56)
Minor 6 (2.6) 35 (15.2) 41 (38.3)
231 13 (5.6) 94 (40.7) 107 (100)
Metronidazole showed agreement in 90% and mild
correlation. Disk diffusion method to metronidazole was
evaluated by Chaves et al. (Chaves et al., 1999), significant
difference to MIC by agar dilution or disk diffusion was not
observed using criteria of susceptible, intermediate and re-
sistant. E-test and disk diffusion presented good correlation
(r = 0.94). Interpretative error rate analysis shows major
rate of errors using disk diffusion method. There is not a
good agreement with agar dilution method. E-test, by the
other hand, showed a good correlation and agreement.
Conclusions
E-test method presented better agreement with gold
standard. It is an easy and reliable method to test
Helicobacter pylori susceptibility. While, disk-diffusion
method presented high disagreement with gold-standard
and high rates of major errors. Probably a lack of break-
point standardization, and different concentration of anti-
microbial in diffusion disks are confouding factors.
However, studies with a larger number of isolates are nec-
essary to evaluate disk diffusion method that is simpler and
cheaper.
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